NovMetaPharma Co., Ltd.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Public
- Established
- 2010-11-04
- Employees
- 19
- Market Cap
- -
- Website
- http://www.novmeta.com
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: Cyclo-ZOther: Placebo
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2019-11-18
- Lead Sponsor
- NovMetaPharma Co., Ltd.
- Target Recruit Count
- 256
- Registration Number
- NCT03560271
- Locations
- πΊπΈ
Study Site 29, Anniston, Alabama, United States
πΊπΈStudy Site 26, Birmingham, Alabama, United States
πΊπΈStudy Site 27, Chula Vista, California, United States
A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus Type 2 in Obese
- Interventions
- Drug: Cyclo-ZDrug: Placebo
- First Posted Date
- 2016-05-27
- Last Posted Date
- 2018-07-12
- Lead Sponsor
- NovMetaPharma Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT02784275
Β© Copyright 2025. All Rights Reserved by MedPath